Wael AlAnazi: Exceptional HLA-Matched Transplant Outcomes With Novel Thiotepa-Based Conditioning
Wael AlAnazi, Chairman and Hematology-Oncology Consultant at King Fahad Specialist Hospital Dammam, shared Syed Osman Ahmed‘s post on LinkedIn, adding:
“Impressive results!!!
I think this may be reference for sickle cell disease transplantation.
Do you have similar observations in Thalassemia?”
Syed Osman Ahmed, Consultant and Adult Hematologist at King Faisal Specialist Hospital and Research Centre, shared a post on LinkedIn about a recent article by Reem Alasbali et al. published in Bone Marrow Transplantation, adding:
“Outstanding outcomes in HLA-matched related donor transplant in adolescents and adults with sickle cell disease!
- 100% 2 year survival
- 0% Transplant related mortality
- 0% graft failure
- 0% Chronic Graft versus host disease
- Only 4% severe acute GVHD
Practice changing.
Congratulations to the authors of this collaborative work by Reem Alasbali et al led by Ali AlAhmari of King Faisal Specialist Hospital and Research Center and teams from Ministry of National Guard Health Affairs, Riyadh, Vanderbilt University Medical Center, Nashville and Imperial College London.”
Title: Excellent outcomes using a novel reduced intensity conditioning with thiotepa and post-transplant cyclophosphamide for HLA-matched related donor transplant in adolescents and adults with sickle cell disease
Authors: Reem Alasbali, Mohsen Alzahrani, Karina Wilkerson, Phavina Akhom, Fahad Alotaibi, Bader Alahmari, Josu de la Fuente, Michael R. DeBaun, Walid Rasheed, Hadeel Samarkandi, Riad El Fakih, Mostafa Saleh, Tusneem Elhassan, Hazza Alzahrani, Mahmoud Aljurf, Fahad Almohareb, Adetola A. Kassim, Ali AlAhmari
Stay updated on all scientific advances with Hemostasis Today.
-
May 26, 2026, 10:26Gestur Vidarsson: Could Antibody Fucosylation Help Predict FNAIT Severity
-
May 26, 2026, 10:17Alan Nurden: New Review Highlights the Importance of Mitochondria in Platelet Function
-
May 26, 2026, 10:12Zoe Cahill: Are We Designing Vascular Grafts for Structure Instead of Biology
-
May 26, 2026, 10:04Dima Shulkin: A Novel Monocyte-Based Biomarker of Cardiovascular Risk
-
May 26, 2026, 09:31Vanduyn Hoven Sibarani: Impact of Pac Dosing on Raw Water Coagulation Performance
-
May 26, 2026, 09:30Sivasooriar Sivaneson: Every Drop of Blood Matters in Pre-Analytical Laboratory Quality
-
May 26, 2026, 08:11Shady AbohashemÖ‰ Stress, Hormones, and Cardiovascular Risk in Women
-
May 26, 2026, 07:39Abdulrahman Nasiri: Managing Refractory Severe Aplastic Anemia During Pregnancy
-
May 26, 2026, 07:21Eman Badr: From Platelets to Precision Oncology